The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Capturing age-related changes in the tumor microenvironment of luminal breast cancer using the multiplex immunohistochemistry technique, MILAN.
 
Yentl Lambrechts
No Relationships to Disclose
 
Asier Antoranz Martinez
No Relationships to Disclose
 
Maxim De Schepper
No Relationships to Disclose
 
Tatjana Geukens
Employment - Siemens Healthineers (I)
Leadership - Siemens Healthineers (I)
Stock and Other Ownership Interests - Siemens Healthineers (I)
 
Hanne Vos
No Relationships to Disclose
 
Lieze Berben
No Relationships to Disclose
 
Julie Messiaen
No Relationships to Disclose
 
Lukas Marcelis
No Relationships to Disclose
 
Yannick Van Herck
No Relationships to Disclose
 
Patrick Neven
Consulting or Advisory Role - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Radius Health (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly (Inst); Pfizer (Inst); Roche (Inst)
 
Ann Smeets
No Relationships to Disclose
 
Kevin Punie
Honoraria - AstraZeneca; Exact Sciences; Focus Patient; Gilead Sciences; Gilead Sciences (Inst); Lilly; Lilly (Inst); Lilly (Inst); MSD; MSD (Inst); Mundipharma (Inst); Novartis; Novartis (Inst); Novartis (Inst); Pfizer; Pfizer; Pfizer (Inst); Pfizer (Inst); Roche; Roche (Inst); Seagen; Seagen (Inst)
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca (Inst); Exact Sciences; Gilead Sciences; Lilly; Lilly (Inst); Lilly (Inst); MSD (Inst); Novartis; Novartis; Novartis; Novartis; Novartis; Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer; Pierre Fabre (Inst); Roche; Roche (Inst); Roche (Inst); Roche (Inst); Sanofi; Seagen; Teva (Inst); Vifor Pharma (Inst)
Research Funding - MSD (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche; Roche; Roche; Roche
Other Relationship - Need
 
Christine Desmedt
Expert Testimony - Lilly (Inst)
 
Francesca Maria Bosisio
No Relationships to Disclose
 
Frederik De Smet
No Relationships to Disclose
 
Sigrid Hatse
No Relationships to Disclose
 
Hans Wildiers
Honoraria - MSD (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo Europe GmbH (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); Lilly (Inst); MSD (Inst); Parexel (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst); Roche (Inst)
 
Giuseppe Floris
Honoraria - AstraZeneca